By Adam Ang April 18, 2022 Detailed atrophy patterns that AI focused on predicting the progression to Alzheimer’s disease Credit: Fujifilm Corporation Fujifilm Corporation has developed AI technology that can predict whether patients with mild cognitive impairment will progress to Alzheimer’s disease within two years. According to a press statement, the AI Technology for AD...
By UNIVERSITY OF CAMBRIDGE OCTOBER 30, 2021 For the first time, researchers have used human data to quantify the speed of different processes that lead to Alzheimer’s disease and found that it develops in a very different way than previously thought. Their results could have important implications for the development of potential treatments. The international team, led by the...
by University of Cambridge Credit: Pixabay/CC0 Public Domain For the first time, researchers have used human data to quantify the speed of different processes that lead to Alzheimer’s disease and found that it develops in a very different way than previously thought. Their results could have important implications for the development of potential treatments. The...
AMERICAN INSTITUTE OF PHYSICS IMAGE: Links between lipid imbalance and disease have been established, in which lipid changes increase the formation of amyloid plaques, a hallmark of Alzheimer’s disease. This imbalance inspired researchers to explore the role of lipids comprising the cellular membranes of brain cells. In Biointerphases, the researchers report on the significant role...
UNIVERSITY OF SOUTH FLORIDA (USF HEALTH) IMAGE: UNIVERSITY OF SOUTH FLORIDA HEALTH NEUROSCIENTIST CHUANHAI CAO, PHD, LED THE PRECLINICAL STUDY TESTING A NOVEL THERAPEUTIC ALZHEIMER’S VACCINE. TAMPA, Fla (Oct. 20, 2020) — Our immune system’s capacity to mount a well-regulated defense against foreign substances, including toxins, weakens with age and makes vaccines less effective in...
